IT8125703A0 - Tri-peptidi, tetra-peptidi o penta-peptidi, loro preparazione e farmaci che li contengono. - Google Patents

Tri-peptidi, tetra-peptidi o penta-peptidi, loro preparazione e farmaci che li contengono.

Info

Publication number
IT8125703A0
IT8125703A0 IT8125703A IT2570381A IT8125703A0 IT 8125703 A0 IT8125703 A0 IT 8125703A0 IT 8125703 A IT8125703 A IT 8125703A IT 2570381 A IT2570381 A IT 2570381A IT 8125703 A0 IT8125703 A0 IT 8125703A0
Authority
IT
Italy
Prior art keywords
peptides
penta
tetra
tri
drugs
Prior art date
Application number
IT8125703A
Other languages
English (en)
Other versions
IT1142148B (it
Inventor
Jean Bouchaudon
Gilles Dutruc-Rosset
Daniel Farge
Claude James
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of IT8125703A0 publication Critical patent/IT8125703A0/it
Application granted granted Critical
Publication of IT1142148B publication Critical patent/IT1142148B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT25703/81A 1980-12-19 1981-12-18 Tri-peptidi, tetra-paptidi o penta-peptidi, loro preparazione e farmaci che li contengono IT1142148B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8027020A FR2496654A1 (fr) 1980-12-19 1980-12-19 Nouveaux tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent

Publications (2)

Publication Number Publication Date
IT8125703A0 true IT8125703A0 (it) 1981-12-18
IT1142148B IT1142148B (it) 1986-10-08

Family

ID=9249292

Family Applications (1)

Application Number Title Priority Date Filing Date
IT25703/81A IT1142148B (it) 1980-12-19 1981-12-18 Tri-peptidi, tetra-paptidi o penta-peptidi, loro preparazione e farmaci che li contengono

Country Status (17)

Country Link
US (1) US4401658A (it)
JP (1) JPS57154151A (it)
AU (1) AU555294B2 (it)
BE (1) BE891539A (it)
CA (1) CA1250398A (it)
CH (1) CH653039A5 (it)
DE (1) DE3150295A1 (it)
DK (1) DK154436C (it)
FR (1) FR2496654A1 (it)
GB (1) GB2089816B (it)
IE (1) IE52113B1 (it)
IT (1) IT1142148B (it)
LU (1) LU83843A1 (it)
NL (1) NL8105587A (it)
NZ (1) NZ199310A (it)
SE (1) SE454699B (it)
ZA (1) ZA818737B (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019383A (en) * 1981-01-09 1991-05-28 New York Blood Center, Inc. Fatty acid carriers for synthetic peptides
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
WO1988001612A1 (en) * 1986-08-27 1988-03-10 Pfizer Inc. Processes and intermediates for n-(s-3-alkyl-heptanoyl)-d-gamma-glutamyl-glycyl-d-alanine
WO1988001613A1 (en) * 1986-08-27 1988-03-10 Pfizer Inc. Crystalline n-(s-3-methylheptanoyl)-d-gamma-glutamyl-glycyl-d-alanine, and processes and intermediates therefor
US4874608A (en) * 1987-04-27 1989-10-17 Imreg, Inc. Therapeutic method for treating malignancies
EP0407605B1 (en) * 1989-01-18 1995-09-13 Sawai Pharmaceutical Co., Ltd. Use of a reagent for detecting antibody corresponding to acid-fast bacterium antigen
US5721109A (en) * 1989-01-18 1998-02-24 Sawai Pharmaceutical Co., Ltd. Method for diagnosing infection caused by acid-fast bacterium
US5136020A (en) * 1989-02-21 1992-08-04 Pfizer Inc. Crystalline n-(s-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor
US5245079A (en) * 1989-02-21 1993-09-14 Pfizer Inc. Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-glycyl-D-alanine
US5248820A (en) * 1989-02-21 1993-09-28 Pfizer Inc. Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor
US5134225A (en) * 1989-02-21 1992-07-28 Pfizer Inc. Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-D-alanine
US5185464A (en) * 1989-02-21 1993-02-09 Pfizer Inc. Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor
DE9110182U1 (it) * 1991-08-17 1992-12-17 Koch Wilhelm Gmbh
AUPO161196A0 (en) * 1996-08-13 1996-09-05 Commonwealth Scientific And Industrial Research Organisation Novel compounds
KR101219880B1 (ko) * 2010-10-08 2013-01-08 한국생산기술연구원 나노 버블을 이용한 두부제조방법
WO2012142659A1 (en) * 2011-04-19 2012-10-26 Baker Idi Heart And Diabetes Institute Holdings Limited Site-selective modification of proteins
EP2975046A1 (en) 2014-07-16 2016-01-20 The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth Novel compounds
CN110092735B (zh) * 2018-01-31 2021-05-11 尚科生物医药（上海）有限公司 一种l-丙氨酸衍生物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
EP0011283B1 (en) * 1978-11-14 1982-07-28 Fujisawa Pharmaceutical Co., Ltd. New lactyl tetrapeptide, processes for preparation thereof and pharmaceutical compositions containing it
US4311640A (en) * 1978-11-14 1982-01-19 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
FR2460289A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tripeptides, leur preparation et les medicaments qui les contiennent
FR2460290A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent

Also Published As

Publication number Publication date
DK154436C (da) 1989-04-17
LU83843A1 (fr) 1982-07-07
GB2089816A (en) 1982-06-30
AU555294B2 (en) 1986-09-18
FR2496654B1 (it) 1983-12-16
CH653039A5 (fr) 1985-12-13
NL8105587A (nl) 1982-07-16
DK154436B (da) 1988-11-14
DK563181A (da) 1982-06-20
JPH0337560B2 (it) 1991-06-05
JPS57154151A (en) 1982-09-22
GB2089816B (en) 1984-07-18
FR2496654A1 (fr) 1982-06-25
ZA818737B (en) 1982-11-24
NZ199310A (en) 1985-10-11
IE812974L (en) 1982-06-19
IE52113B1 (en) 1987-06-24
BE891539A (fr) 1982-06-18
AU7859081A (en) 1982-06-24
DE3150295A1 (de) 1982-07-29
US4401658A (en) 1983-08-30
IT1142148B (it) 1986-10-08
SE8107634L (sv) 1982-06-20
SE454699B (sv) 1988-05-24
CA1250398A (fr) 1989-02-21

Similar Documents

Publication Publication Date Title
IT8023072A0 (it) Tetra-peptidi oppure penta-peptidi, loro preparazione e prodotti medicinali che li contengono.
IT8125703A0 (it) Tri-peptidi, tetra-peptidi o penta-peptidi, loro preparazione e farmaci che li contengono.
NL930046I2 (nl) Gesubstitueerde iminodizuren, hun bereiding en henbevattende farmaceutische mengsels.
IT8122682A0 (it) Loro preparazione. interferoni e procedimento per la
IT1219940B (it) Benzo-b-pirani e piranopiridone,loro preparazione e loro impiego come medicamenti
DK175487A (da) Farmaceutisk aktive 2-thiomethyl-substitueret-1,4-dihydro-pyridiner
IT1189229B (it) Polipeptedi,loro preparazione e loro impiego come medicamenti
IT8323205A0 (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
NO882653D0 (no) Doseringsform.
IT1199964B (it) Alfa-amminoacidi,la loro preparazione e lecoomposizioni farmaceutiche che li contengono
DE68907177T2 (de) Dosierungsform.
DE3683664D1 (de) Pharmazeutisches tablettierverfahren.
IT8323396A0 (it) Antimuscarinica. composizione farmaceutica adattivita' sistemica anticolinesterasica, agonista-colinergica ed
IT1197644B (it) Azepinoindoli,loro preparazione e loro impiego come medicamenti
IT8023073A0 (it) Dipeptidi, loro preparazione e prodotti medicinali che licontengono.
IT1203816B (it) Disaccaridi,loro preparazione e loro impiego come medicamenti
IT1169770B (it) Polipeptidi, loro preparazione e loro impiego come medicamenti
IT8023074A0 (it) Tripeptidi, loro preparazione e prodotti medicinali che licontengono.
IT8419657A0 (it) Farmaci contenenti muzolimin, loro impiego e procedimenti per la loro produzione.
IT8548964A0 (it) 8alfa-acilamminoergoline,loro preparazione e composizioni farmaceutiche che le contengono
IT8123488A0 (it) Metaboliti, loro preparazione eloro impiego in terapeutica.
JPS5775969A (en) N-(1-aryl-2-pyrrolidinylmethyl)-2-methoxy-4- amino-5-methylsulfamoylbenzamide, manufacture and analgesic thereof as effective ingredient
IT1206323B (it) Preparazioni farmaceutiche con azione citostatica.
IT1213160B (it) Aminoalchilen-eteri e tioeteri naftalenici e loro impieghi farmaceutici.
IT8123860A0 (it) 4-carbamoilossi-ossazafosforine metodo per produrle e preparazioni farmaceutiche che le contengono.